- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Alzheimer Disease Type 2 in Colombia
Total 2817 results
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | AlbuminuriaAustralia, France, Italy, Poland, Ukraine, United Kingdom, United States, China, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Malaysia, Canada, Netherlands, Korea, Republic of, New Zealand, Brazil, Russian Federation, Puerto... and more
-
NestléNestec Ltd.; Regulatory and Clinical Research Institute Inc; Cytel Inc.TerminatedStroke | Multiple Sclerosis | Parkinson Disease | Dementia | Alzheimer Disease | Oropharyngeal DysphagiaUnited States, Finland
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Colombia, Mexico, Poland, Spain, India, Malaysia, Romania, South Africa, Sweden, Korea, Republic of, Estonia, Puerto Rico, Austria, Lithuania, Philippines, Guatemala, Iceland
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
-
Anji PharmaSuspendedDiabetes Mellitus, Type 2Spain, United States, Canada, Hungary, Brazil, Czechia, Poland, Bulgaria
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, Greece, India, Philippines, Thailand, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Canada, Poland, South Africa, Slovakia
-
PfizerCompletedDiabetes Mellitus, Type 2Canada, United States, Korea, Republic of, Puerto Rico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Georgia, Greece, Hong Kong, Hungary, India, Indonesia, Israel, Italy, Japan, Korea, Republic of, Malaysia and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Thailand, Korea, Republic of, United Kingdom, China, Germany, Israel, Mexico, Argentina, Brazil, Colombia, Puerto Rico, Russian Federation
-
Children's National Research InstituteAmerican Diabetes AssociationActive, not recruitingType 1 Diabetes MellitusUnited States
-
University of Missouri-ColumbiaUniversity of WashingtonRecruiting
-
Hospital Pablo Tobón UribeUniversidad de AntioquiaCompletedDiabetes Mellitus, Type 1Colombia
-
TakedaTakeda Development Center Americas, Inc.CompletedDiabetes Mellitus, Type 2United States, Italy, Mexico, Russian Federation, Brazil, Israel, Poland
-
AstraZenecaCompleted
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Universidad de AntioquiaCompletedDiabetes Mellitus, Type 1Colombia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Argentina, Macedonia, The Former Yugoslav Republic of, Slovenia, Canada, Brazil
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Germany, Spain, Taiwan, Hungary, Poland, Korea, Republic of, Austria, New Zealand, United Kingdom, Czechia, Puerto Rico
-
NovartisTerminatedDiabetes Mellitus, Type 2Germany, United Kingdom, Turkey, United States, Belgium, Japan, Korea, Republic of, Romania, Argentina, Peru, South Africa, India, China, Hungary
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Argentina, Austria, Belgium, Canada, China, Croatia, Czech Republic, Finland, Germany, Greece, Hungary, India, Israel, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Poland, R... and more
-
Intarcia TherapeuticsTerminatedDiabetes Mellitus, Type 2United States, Canada
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Brazil, Canada, El Salvador, France, Korea, Republic of, New Zealand, Norway, Spain, Taiwan
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand
-
University of British ColumbiaJuvenile Diabetes Research FoundationUnknown
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Netherlands, Russian Federation, India, Belgium, Japan, Romania, Italy
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Slovakia, Canada, Austria, Hungary, Serbia, Russian Federation, Bulgaria, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, South Africa, Romania, Brazil, China, Ukraine
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Canada, Korea, Republic of, Australia, New Zealand, Mexico, Brazil
-
Eli Lilly and CompanyCompletedCardiovascular Disease | Diabetes Mellitus, Type 2Argentina, Canada, Germany, Spain, United Kingdom, United States, Hungary, Puerto Rico, Bulgaria, Poland, Korea, Republic of, Australia, Brazil, Mexico, Chile, Colombia, Czechia, Latvia, Lithuania, New Zealand, Romania, Russian Federation and more
-
University of British ColumbiaJuvenile Diabetes Research Foundation; Brain CanadaNot yet recruiting
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2United States, France, Netherlands
-
GlaxoSmithKlinePopulation Health Research InstituteTerminatedDiabetes Mellitus, Type 2United States, Germany, Russian Federation, Netherlands, South Africa, Sweden, Canada, Norway, United Kingdom, Latvia, Thailand, Colombia, India, Peru, Romania, Pakistan, Slovakia, Finland, Chile, Denmark, Argentina, Mexico, Czech Republic and more
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Korea, Republic of, Australia, India, Canada, Japan, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada
-
BayerRecruitingType 2 Diabetes Mellitus | Chronic Kidney DiseaseUnited States, Germany, Argentina, Belgium, Brazil, Canada, Chile, Colombia, France, Italy, Korea, Republic of, Luxembourg, Mexico, Netherlands, Russian Federation, Saudi Arabia, Singapore, Slovenia, Spain, Switzerland, Taiwan, Th... and more
-
AstraZenecaCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); BC Children's Hospital Research...RecruitingAdolescent | Child | Type 1 Diabetes | Cardiovascular ComplicationsCanada
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Russian Federation, Spain, United Kingdom, Austria, Belgium, Mexico, Sweden, Israel, Taiwan, Hungary, Malaysia, Serbia, Turkey, Denmark, Greece, Thailand, North Macedonia, Norway, Portugal, Germany, Romania and more